Global Coagulation Factor Concentrate Sales Market by Type (Coagulation Factor IX, Coagulation Factor XIII, Others), By Application (Hospitals and Clinics, Research Laboratories, Academic Institutions) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

The Global Coagulation Factor Concentrate Market size is projected to grow at a CAGR of around 3.7% during the forecast period 2021-2028. The growth will be driven by the growing demand for coagulation factors in hospitals and clinics, research laboratories, academic institutions across various regions of the world.

Coagulation factor concentrate is a blood product that contains coagulation factors, which are proteins needed for normal clotting. Coagulation factors are often deficient in people with certain bleeding disorders, such as hemophilia. Coagulation factor concentrates can be used to treat and prevent bleeds in patients with deficiencies or inhibitors of these clotting factors. Patients who have coagulation factor deficiencies may require infusions every few days because their bodies cannot make enough of the missing proteins on their own. Coagulation factor concentrates are often infused intravenously, but can also be given by injection. Coagulation factor concentrate may come in powder form and is mixed with a liquid before use. It should only be used when directed by a healthcare professional to avoid serious side effects such as the increased risk of infection or bleeding complications.

On the basis of Type, the global coagulation factor concentrate market is segmented into Coagulation Factor IX, Coagulation Factor XIII, Others.

Coagulation Factor IX:

In the human body, coagulation factor IX is a protein that plays an important role in blood clotting. It helps stop bleeding by helping platelets stick together to form a plug over the wound site which stops further loss of blood from broken vessels. In this way, it acts as a hemostatic agent and prevents hemorrhage. However, its main function remains unchanged throughout life despite age or disease processes/disorders affecting other functions of the body. Coagulation Factor IX also called Lepirudin (Refludan) is used for treatment & prevention of hemophilia B with inhibitors; control/prophylaxis and treatment of bleeding in patients with acquired hemophilia A.

Coagulation Factor XIII:

Coagulation Factor XIII is a protein that serves as the glue-producing enzyme, binding proteins together. It acts on two enzymes called factor XI and prekallikrein to activate them which helps fix fibrinogen into long strands by converting it into fibrin monomers then further polymerize these polymers into a stronger cross-linked network known as fibers or filaments. This makes it vital for proper hemostasis during wound healing.

On the basis of Application, the global coagulation factor concentrate market is segmented into Hospitals and Clinics, Research Laboratories.

Hospitals And Clinics:

It is used for the treatment of bleeding and clotting disorders. It is also used to treat hemophilia A, Hemophilia B, and von Willebrand disease (vWD). Coagulation factor concentrates are used for surgical procedures, including open heart surgery and neurosurgery. They also help with the treatment of bleeding disorders like von Willebrand disease (VWD), hemophilia A, hemophilia B, disseminated intravascular coagulation (DIC) among others.

Research Laboratories:

Coagulation factor concentrate is used for a variety of applications in research laboratories, including: To conduct studies that determine the safety and/or efficacy of recombinant coagulation factors, To conduct preclinical studies for the development of new coagulation factor products, To support the development of new assays, reagents and tests to aid in monitoring disease activity, To conduct studies that are part of an investigational drug application (e.g., IND or NDA), For use in quality control assays to ensure that each batch produced meets standards set by regulatory bodies, To collect blood samples from patients who have been given prothrombin complex concentrates (PCCs) prior to surgery or other invasive procedures. This allows clinicians to measure their anticoagulant effects before administration.

On the basis of Region, the global coagulation factor concentrate market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. The North American region holds the largest share in the global coagulation factor concentrate market, by region. The countries of this region are projected to witness considerable growth over the forecast period 2018-2028 owing to increasing demand for advanced medical tools and devices including coagulation factor concentrates among others. The Latin American Coagulation Factor Concentrate Market is expected to grow at a CAGR of around 18% during the forecast period. Latin America is a key market for the coagulation factor concentrate.

The market for coagulation factor concentrate in Europe is expected to grow at a CAGR of around +17.0% from 2017-2022. The driver behind this growth can be attributed to the rising prevalence of thrombotic diseases, growing demand for plasma-based products such as coagulation factor concentrates, and increasing research funding across European countries especially those that focus on R&D activities related to hemophilia therapy. This revenue generation opportunity will drive many players operating within this space towards expanding their geographical reach and investing heavily into building sustainable marketing strategies aimed at promoting awareness regarding their product portfolio amongst end-users and healthcare professionals alike.

Growth Factors For The Global Coagulation Factor Concentrate Market:

The growth will be primarily attributed to the growing demand for hematopoietic stem cell transplantation procedures across the globe due to the rising prevalence of blood cancers such as leukemia & lymphoma etc., increasing geriatric population base with increase risk of bleeding disorders, and rising prevalence of hemophilia A & B. Furthermore, growing demand for coagulation factor concentrates in emerging economies including China, Brazil, etc., is expected to drive the market over the forecast period 2017-2028.

Up Market Research published a new report titled “Coagulation Factor Concentrate Sales Market research report which is segmented by Types (Coagulation Factor IX, Coagulation Factor XIII, Others), By Applications (Hospitals and Clinics, Research Laboratories, Academic Institutions), By Players/Companies Medscape, CSL Behring, Octapharma”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.

Report Scope

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Global Coagulation Factor Concentrate Sales Market Report Segments:

The market is segmented by Type Coagulation Factor IX, Coagulation Factor XIII, Others and By Application Hospitals and Clinics, Research Laboratories, Academic Institutions.

Some of the companies that are profiled in this report are:

1. Medscape
2. CSL Behring
3. Octapharma

Coagulation Factor Concentrate Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.

Key Benefits for Industry Participants & Stakeholders:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Coagulation Factor Concentrate Sales Market

Overview of the regional outlook of the Coagulation Factor Concentrate Sales Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.

Highlights of The Coagulation Factor Concentrate Sales Market Report:

1. The market structure and projections for the coming years.
2. Drivers, restraints, opportunities, and current trends of Coagulation Factor Concentrate Sales Market.
3. Historical data and forecast.
4. Estimations for the forecast period 2028.
5. Developments and trends in the market.
6. By Type:

                1. Coagulation Factor IX

                2. Coagulation Factor XIII

                3. Others

                1. Hospitals and Clinics

                2. Research Laboratories

                3. Academic Institutions

8. Market scenario by region, sub-region, and country.
9. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
10. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
11. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Coagulation Factor Concentrate Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

How you may use our products:

• Correctly Positioning New Products
• Market Entry Strategies
• Business Expansion Strategies
• Consumer Insights
• Understanding Competition Scenario
• Product & Brand Management
• Channel & Customer Management
• Identifying Appropriate Advertising Appeals

Reasons to Purchase the Coagulation Factor Concentrate Sales Market Report:

• The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
• Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
• Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
• The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
• Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.